These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28236969)

  • 1. Glycogen Synthase Kinase 3: A Kinase for All Pathways?
    Patel P; Woodgett JR
    Curr Top Dev Biol; 2017; 123():277-302. PubMed ID: 28236969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen synthase kinase 3 in Wnt signaling pathway and cancer.
    Tejeda-Muñoz N; Robles-Flores M
    IUBMB Life; 2015 Dec; 67(12):914-22. PubMed ID: 26600003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen synthase kinases: Moonlighting proteins with theranostic potential in cancer.
    Nagini S; Sophia J; Mishra R
    Semin Cancer Biol; 2019 Jun; 56():25-36. PubMed ID: 29309927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of glycogen synthase kinase-3.
    Ougolkov AV; Billadeau DD
    Methods Mol Biol; 2008; 468():67-75. PubMed ID: 19099246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen synthase kinase 3: a key regulator of cellular fate.
    Forde JE; Dale TC
    Cell Mol Life Sci; 2007 Aug; 64(15):1930-44. PubMed ID: 17530463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new strategy for studying protein kinase B and its three isoforms. Role of protein kinase B in phosphorylating glycogen synthase kinase-3, tuberin, WNK1, and ATP citrate lyase.
    Sale EM; Hodgkinson CP; Jones NP; Sale GJ
    Biochemistry; 2006 Jan; 45(1):213-23. PubMed ID: 16388597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism.
    MacAulay K; Doble BW; Patel S; Hansotia T; Sinclair EM; Drucker DJ; Nagy A; Woodgett JR
    Cell Metab; 2007 Oct; 6(4):329-37. PubMed ID: 17908561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen synthase kinase-3--an overview of an over-achieving protein kinase.
    Kockeritz L; Doble B; Patel S; Woodgett JR
    Curr Drug Targets; 2006 Nov; 7(11):1377-88. PubMed ID: 17100578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and regulation of glycogen synthase kinase 3 in human neutrophils.
    Giambelluca MS; Cloutier N; Rollet-Labelle E; Boilard E; Pouliot M
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2660-5. PubMed ID: 24035907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSK-3 mediates the okadaic acid-induced modification of collapsin response mediator protein-2 in human SK-N-SH neuroblastoma cells.
    Ni MH; Wu CC; Chan WH; Chien KY; Yu JS
    J Cell Biochem; 2008 Apr; 103(6):1833-48. PubMed ID: 17902168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of glycogen synthase kinase-3β in cartilage results in up-regulation of glycogen synthase kinase-3α protein expression.
    Gillespie JR; Ulici V; Dupuis H; Higgs A; Dimattia A; Patel S; Woodgett JR; Beier F
    Endocrinology; 2011 May; 152(5):1755-66. PubMed ID: 21325041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword?
    Patel S; Doble B; Woodgett JR
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):803-8. PubMed ID: 15494020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase 3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles.
    Galliher-Beckley AJ; Williams JG; Collins JB; Cidlowski JA
    Mol Cell Biol; 2008 Dec; 28(24):7309-22. PubMed ID: 18838540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
    Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6.
    Stamos JL; Chu ML; Enos MD; Shah N; Weis WI
    Elife; 2014 Mar; 3():e01998. PubMed ID: 24642411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presenilin-1 is an unprimed glycogen synthase kinase-3beta substrate.
    Twomey C; McCarthy JV
    FEBS Lett; 2006 Jul; 580(17):4015-20. PubMed ID: 16814287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSK-3β negatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitro.
    Ono M; Matsubara Y; Shibano T; Ikeda Y; Murata M
    Platelets; 2011; 22(3):196-203. PubMed ID: 21231855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibitors of glycogen synthase kinase 3.
    Meijer L; Flajolet M; Greengard P
    Trends Pharmacol Sci; 2004 Sep; 25(9):471-80. PubMed ID: 15559249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSK3 in Alzheimer's disease: mind the isoforms.
    Ma T
    J Alzheimers Dis; 2014; 39(4):707-10. PubMed ID: 24254703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen synthase kinase-3beta is activated by matrix metalloproteinase-2 mediated proteolysis in cardiomyoblasts.
    Kandasamy AD; Schulz R
    Cardiovasc Res; 2009 Sep; 83(4):698-706. PubMed ID: 19493954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.